Skip to main content
Premium Trial:

Request an Annual Quote

Nanogen Opens European Sales Office in the Netherlands

NEW YORK, Sept 27 – Chip-maker Nanogen (Nasdaq: NGEN) said Wednesday that it has created Nanogen Europe to extend its marketing and sales efforts throughout the continent.

San Diego-based Nanogen, which only recently began marketing its NanoChip system to scientists and genomics laboratories for single-nucleotide polymorphism scoring, made its first commercial sale to French life sciences company Aventis (NYSE: AVE) in June. And a week ago it sold the system to German food additives company SKW Nature Products.

Howard Birndorf, chairman and CEO of Nanogen said in a statement that the new unit was created because he sees Europe as “a potentially important market.”

Roderik van den Bogaard, formerly of Molecular Dynamics and Spectra Physics, has been named managing director of the company’s wholly owned subsidiary based in Helmond, the Netherlands.

Nanogen was up 1/16, or 0.33 percent, at 18 3/4 in afternoon trading.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.